<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">COLESEVELAM HYDROCHLORIDE</span><br/>(co-less'e-ve-lam)<br/><span class="topboxtradename">Welchol<br/></span><b>Classifications:</b> <span class="classification">cardiovascular agent</span>; <span class="classification">antilipemic</span>; <span class="classification">bile acid sequestrant</span><br/><b>Prototype: </b>Cholestyramine Resin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>625 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Anion exchange resin used for its cholesterol-lowering effect. Binds with bile salts in the intestinal tract to form an insoluble
         complex that is excreted in the feces, thus reducing circulating cholesterol and increasing serum LDL removal rate. Serum
         triglyceride levels may increase slightly.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Decreases serum LDL and total cholesterol level. Removes bile salts from the intestine.</p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunctive therapy to diet and exercise for reduction of elevated LDL cholesterol alone or in combination with an HMG-CoA
         reductase inhibitor (statin).
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to colesevelam; complete biliary obstruction; bowel obstruction; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Preexisting GI disorders or bowel disease, primary biliary cirrhosis, partial biliary obstruction, biliary atresia; hypertriglyceridemia;
         older adults, pregnancy (category B), lactation; malabsorption states; bleeding disorders.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Hypercholesterolemia, Monotherapy</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 3 tablets b.i.d. with meals or 6 tablets q.d. with a meal, may be increased to 7 tablets/d<br/><br/><span class="indicationtitle">Hypercholesterolemia, Combination Therapy</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 46 tablets/d with meals or 6 tablets q.d. with a meal<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with meals (mandatory) and adequate liquid (e.g., 8 oz).</li>
<li>Store at 15°30° C (59°86° F) with occasional fluctuations to 40° C (90° F); protect
            from moisture.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Infection, pain, flu-like syndrome, asthenia, myalgia. <span class="typehead"> CNS:</span> Headache. <span class="typehead">GI:</span> Abdominal pain, <span class="speceff-common">flatulence, constipation,</span> diarrhea, nausea, dyspepsia. <span class="typehead">Respiratory:</span> Sinusitis, rhinitis, cough, pharyngitis. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May decrease absorption of <b>verapamil.</b> Can bind and affect absorption of any drug. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Not absorbed. <span class="typehead">Metabolism:</span> Not metabolized. <span class="typehead">Elimination:</span> Excreted in feces. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: Monitor total cholesterol, LDL-C, HDL-C, and triglycerides periodically.</li>
<li>Withhold drug and notify physician for triglycerides &gt;300 mg/dL.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report S&amp;S of GI distress (see Appendix F), especially constipation.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>